Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation

J. Y. Wang, T. F. Yeh, Y. J. Lin, W. Y. Chen, C. H. Lin

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Early postnatal use of dexamethasone has recently been shown to be effective in improving the pulmonary status in premature infants with respiratory distress syndrome (RDS). To study the effect of dexamethasone on pulmonary inflammatory responses, we studied ten infants treated with dexamethasone and ten infants without this treatment. Serial tracheal aspirates were obtained for cell counts, neutrophil counts, total protein concentrations, and leukotriene B4 (LTB4) and 6-keto prostaglandin (PGF(1α) levels before and after starting the study. Infants in the dexamethasone-treated group required significantly lower mean airway pressures for ventilation and had lower P(a)CO2 values from day 3 to day 14 than infants in the control group, suggesting better pulmonary function. For infants in the dexamethasone group, the tracheal aspirates showed significantly lower cell and neutrophil counts, protein concentrations, and 6-keto-PGF(1α) and LTB4 levels than in the control group. We conclude that early postnatal dexamethasone therapy may lessen lung inflammation and improve pulmonary function in infants with RDS.

Original languageEnglish
Pages (from-to)193-197
Number of pages5
JournalPediatric Pulmonology
Volume23
Issue number3
DOIs
Publication statusPublished - Mar 1 1997
Externally publishedYes

Fingerprint

Artificial Respiration
Dexamethasone
Pneumonia
Lung
Leukotriene B4
Prostaglandins F
Neutrophils
Therapeutics
Cell Count
Newborn Respiratory Distress Syndrome
Control Groups
Prostaglandins
Ventilation
Respiratory Distress Syndrome In Premature Infants
Proteins
Pressure

Keywords

  • 6-keto-PGF(1α) leukotriene B
  • bronchopulmonary dysplasia
  • dexamethasone
  • respiratory distress syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation. / Wang, J. Y.; Yeh, T. F.; Lin, Y. J.; Chen, W. Y.; Lin, C. H.

In: Pediatric Pulmonology, Vol. 23, No. 3, 01.03.1997, p. 193-197.

Research output: Contribution to journalArticle

@article{f65ba49a9a9e47daa101b4817d57c909,
title = "Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation",
abstract = "Early postnatal use of dexamethasone has recently been shown to be effective in improving the pulmonary status in premature infants with respiratory distress syndrome (RDS). To study the effect of dexamethasone on pulmonary inflammatory responses, we studied ten infants treated with dexamethasone and ten infants without this treatment. Serial tracheal aspirates were obtained for cell counts, neutrophil counts, total protein concentrations, and leukotriene B4 (LTB4) and 6-keto prostaglandin (PGF(1α) levels before and after starting the study. Infants in the dexamethasone-treated group required significantly lower mean airway pressures for ventilation and had lower P(a)CO2 values from day 3 to day 14 than infants in the control group, suggesting better pulmonary function. For infants in the dexamethasone group, the tracheal aspirates showed significantly lower cell and neutrophil counts, protein concentrations, and 6-keto-PGF(1α) and LTB4 levels than in the control group. We conclude that early postnatal dexamethasone therapy may lessen lung inflammation and improve pulmonary function in infants with RDS.",
keywords = "6-keto-PGF(1α) leukotriene B, bronchopulmonary dysplasia, dexamethasone, respiratory distress syndrome",
author = "Wang, {J. Y.} and Yeh, {T. F.} and Lin, {Y. J.} and Chen, {W. Y.} and Lin, {C. H.}",
year = "1997",
month = "3",
day = "1",
doi = "10.1002/(SICI)1099-0496(199703)23:3<193::AID-PPUL4>3.0.CO;2-P",
language = "English",
volume = "23",
pages = "193--197",
journal = "Pediatric Pulmonology",
issn = "8755-6863",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation

AU - Wang, J. Y.

AU - Yeh, T. F.

AU - Lin, Y. J.

AU - Chen, W. Y.

AU - Lin, C. H.

PY - 1997/3/1

Y1 - 1997/3/1

N2 - Early postnatal use of dexamethasone has recently been shown to be effective in improving the pulmonary status in premature infants with respiratory distress syndrome (RDS). To study the effect of dexamethasone on pulmonary inflammatory responses, we studied ten infants treated with dexamethasone and ten infants without this treatment. Serial tracheal aspirates were obtained for cell counts, neutrophil counts, total protein concentrations, and leukotriene B4 (LTB4) and 6-keto prostaglandin (PGF(1α) levels before and after starting the study. Infants in the dexamethasone-treated group required significantly lower mean airway pressures for ventilation and had lower P(a)CO2 values from day 3 to day 14 than infants in the control group, suggesting better pulmonary function. For infants in the dexamethasone group, the tracheal aspirates showed significantly lower cell and neutrophil counts, protein concentrations, and 6-keto-PGF(1α) and LTB4 levels than in the control group. We conclude that early postnatal dexamethasone therapy may lessen lung inflammation and improve pulmonary function in infants with RDS.

AB - Early postnatal use of dexamethasone has recently been shown to be effective in improving the pulmonary status in premature infants with respiratory distress syndrome (RDS). To study the effect of dexamethasone on pulmonary inflammatory responses, we studied ten infants treated with dexamethasone and ten infants without this treatment. Serial tracheal aspirates were obtained for cell counts, neutrophil counts, total protein concentrations, and leukotriene B4 (LTB4) and 6-keto prostaglandin (PGF(1α) levels before and after starting the study. Infants in the dexamethasone-treated group required significantly lower mean airway pressures for ventilation and had lower P(a)CO2 values from day 3 to day 14 than infants in the control group, suggesting better pulmonary function. For infants in the dexamethasone group, the tracheal aspirates showed significantly lower cell and neutrophil counts, protein concentrations, and 6-keto-PGF(1α) and LTB4 levels than in the control group. We conclude that early postnatal dexamethasone therapy may lessen lung inflammation and improve pulmonary function in infants with RDS.

KW - 6-keto-PGF(1α) leukotriene B

KW - bronchopulmonary dysplasia

KW - dexamethasone

KW - respiratory distress syndrome

UR - http://www.scopus.com/inward/record.url?scp=0030940126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030940126&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-0496(199703)23:3<193::AID-PPUL4>3.0.CO;2-P

DO - 10.1002/(SICI)1099-0496(199703)23:3<193::AID-PPUL4>3.0.CO;2-P

M3 - Article

VL - 23

SP - 193

EP - 197

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

SN - 8755-6863

IS - 3

ER -